ICON PLC — Investor Relations & Filings
ICON PLC is a global provider of outsourced development and commercialization services for the pharmaceutical, biotechnology, and medical device sectors. The company supports clients in accelerating the development of drugs and devices, offering a comprehensive suite of services that span the entire clinical lifecycle from "molecule to medicine." Core capabilities include consulting, early clinical and bioanalytical solutions, site and patient solutions, specialty laboratory services supporting precision medicine, and market access strategies covering pricing and reimbursement. ICON also delivers specialized biotech support, such as due diligence and asset valuation, alongside advanced cardiac safety solutions. The company integrates healthcare intelligence and technology, including artificial intelligence, to enhance clinical research processes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | |
| 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 38523041 | 6-K - ICON PLC (0001060955) (Filer) | 2026-04-29 | English | ||
| 32979428 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979257 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979034 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979027 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978975 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979000 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978992 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32978823 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 32979004 | 3 - ICON PLC (0001060955) (Issuer) | 2026-03-18 | English | ||
| 27010870 | 6-K Filing | 2026-01-07 | English | ||
|
2025
4 filings
| |||||
| 11036694 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 11036695 | Major Shareholding Notification 2025 | 2025-11-12 | English | ||
| 11036696 | 6-K | 2025-11-12 | English | ||
| 11036697 | Regulatory Filings 2025 | 2025-11-03 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for ICON PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Linical Co., Ltd.
A global CRO providing a full spectrum of drug development …
|
2183 | JP | Professional, scientific and te… |
|
Lipigon Pharmaceuticals AB
A clinical-stage company developing therapeutics for lipid-…
|
LPGO | SE | Professional, scientific and te… |
|
Lipum AB
Clinical-stage biopharma developing novel treatments for ch…
|
LIPUM | SE | Professional, scientific and te… |
|
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
Clinical-stage pharma company developing PP2A inhibitors to…
|
LIXT | US | Professional, scientific and te… |
|
Lunai Bioworks Inc.
Pre-clinical biotech company using AI for drug discovery an…
|
RENB | US | Professional, scientific and te… |
|
LYSOGENE
A former clinical-stage biotech that developed gene therapi…
|
LYS | FR | Professional, scientific and te… |
|
MaaT Pharma
A clinical-stage biotech developing microbiome-based therap…
|
MAAT | FR | Professional, scientific and te… |
|
Many Bright Ideas Technologies Inc.
Acquires, develops, and commercializes IP, emphasizing alte…
|
MBI.H | CA | Professional, scientific and te… |
|
MapLight Therapeutics, Inc.
Develops targeted therapies for CNS disorders using circuit…
|
MPLT | US | Professional, scientific and te… |
|
Marvel Biosciences Corp.
Developing transformative treatments for complex neurologic…
|
MRVL | CA | Professional, scientific and te… |
ICON PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30483/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30483 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30483 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30483 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30483}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ICON PLC (id: 30483)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.